A robust in vitro model for trans-lymphatic endothelial migration.

Citation data:

Scientific reports, ISSN: 2045-2322, Vol: 7, Issue: 1, Page: 1633

Publication Year:
2017
Usage 2
Abstract Views 2
Social Media 2
Tweets 2
PMID:
28487567
DOI:
10.1038/s41598-017-01575-w
Author(s):
Xiong, Yanbao, Brinkman, C Colin, Famulski, Konrad S, Mongodin, Emmanuel F, Lord, Colin J, Hippen, Keli L, Blazar, Bruce R, Bromberg, Jonathan S
Publisher(s):
Springer Nature
Tags:
Multidisciplinary
Most Recent Tweet View All Tweets
article description
Trans-endothelial migration (TEM) is essential for leukocyte circulation. While much is known about trans-blood endothelial migration, far less is known about trans-lymphatic endothelial migration. We established an in vitro system to evaluate lymphatic TEM for various cell types across primary mouse and human lymphatic endothelial cells (LEC), and validated the model for the murine LEC cell line SVEC4-10. T cells exhibited enhanced unidirectional migration from the basal (abluminal) to the apical (luminal) surface across LEC, whereas for blood endothelial cells (BEC) they migrated similarly in both directions. This preferential, vectorial migration was chemotactic toward many different chemoattractants and dose-dependent. Stromal protein fibers, interstitial type fluid flow, distribution of chemokines in the stromal layer, and inflammatory cytokines influenced LEC phenotype and leukocyte TEM. Activated and memory CD4 T cells, macrophages, and dendritic cell (DC) showed chemoattractantΔdriven vectorial migration, while CD8 T cell migration across LEC was not. The system was further validated for studying cancer cell transmigration across lymphatic endothelium. This model for lymphatic TEM for various migrating and endothelial cell types possesses the capacity to be high-throughput, highly reproducible and integrate the complexities of lymphatic biology, stromal variability, chemoattractant distribution, and fluid flow.

This article has 0 Wikipedia mention.